Praxair to Build Air Separation Plant and Pipeline at Antwerp


U.S. industrial gases producer Praxair is building its second air separation plant and extending its pipeline system in the Port of Antwerp, the world's second largest chemical complex after Houston, Texas.
The company said the new 1,300 t/d plant, to start up in early 2016, will increase its oxygen and nitrogen capacity in the port and will expand supply to several of its global customers with facilities there. Additionally, the pipeline system will be capable of distributing liquid oxygen, nitrogen and argon to support producers of pharmaceuticals and chemicals as well as other products in Belgium and the Netherlands.
A number of major chemical companies, including Total, have revealed expansion plans for the Belgian hub. According to the Antwerp Port Authority, already announced investments will exceed € 1 billion, and projects worth an additional €1 billion expected to materialize there in the near future.
"The increase of installed capacity, as well as an expansion of Praxair's pipeline network in the Port of Antwerp, gives us the reach and production to supply the increasing oxygen and nitrogen demand of customers throughout the port," said Todd Skare, president of Praxair Europe. "Integrated ports such as Antwerp have remained competitive, in spite of the extended recessionary period in Europe, and we fully expect the port to continue to grow and attract significant new investment in the future," he added.
Eddy Bruyninckx, CEO of the port authority, said the new Praxair investment will enhance the competitiveness of the companies active at Antwerp.
most read

Future Prospects in Green Chemistry
The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.

Vynova Alkoxides Awards Engineering Contract for New Plant
Vynova Alkoxides GmbH is beginning the construction of a new alcoholates plant at Chemiepark Lülsdorf GmbH in Lülsdorf, Germany.

Samsung Biologics Signs Manufacturing Deal with European Pharmaceutical Company
Samsung Biologics, a global contract development and manufacturing organization (CDMO), recently announced a series of manufacturing deals with a Europe-based pharmaceutical company.

Data-Driven Enzyme Immobilization
Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.

New Deal to Boost Competitiveness
The EU Green Deal has hurt Europe's industry. The Clean Industrial Deal aims to improve this, but a change of mindset at the Commission is needed.